| Literature DB >> 29190995 |
Juping Zhao1, Jun Dai1, Wenlong Zhou1, Haofei Wang1, Wenbin Rui1, Wei He1, Zhe Zhu2,3, Yu Zhu1, Danfeng Xu1, Fukang Sun1.
Abstract
Study about blood pressure variation in the first 24 hours post-operation is limited in patients with adrenal aldosterone-producing adenoma. We aim to evaluate the potential predictors for postoperative hypertension urgency during the first 24 hours after laparoscopic adrenalectomy in patients with aldosterone-producing adenoma. Clinical data of 177 patients with aldosterone-producing adenoma were retrospectively collected from January 2009 to December 2015 and the potential factors that may influence postoperative blood pressure during the first 24 hours after surgery were analyzed. The factors included gender, age, body mass index, preoperative maximum systolic blood pressure, number of antihypertensive medicines, preoperative spironolactone treatment, duration of hypertension, surgical method and approach, adenoma diameter, preoperative proteinuria, estimated glomerular filtration rate, serum potassium and serum aldosterone. Univariate and multivariate regression analyses were used to evaluate the relationship between the above variables and postoperative hypertension urgency. We found that the proportion of patients with a higher systolic blood pressure ≥ 160 mmHg and ≥ 180 mmHg were significantly increased post-operation (both p < 0.001). In multivariate analysis, the maximum systolic blood pressure was an independent predictor of postoperative hypertension urgency, and the cut-off point was 157 mmHg with the sensitivity of 66% and specificity of 82%. Multivariable analysis also showed that preoperative maximum systolic blood pressure and number of antihypertensive medicines were independent risk factors for higher postoperative systolic blood pressure. This study was derived from a high volume adrenal tumor center, and these data may provide a potential tool to guide preoperative counseling.Entities:
Keywords: aldosterone-producing adenoma; hypertension urgency; laparoscopic adrenalectomy; predictor
Year: 2017 PMID: 29190995 PMCID: PMC5696261 DOI: 10.18632/oncotarget.21632
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Characteristics of 177 patients with adrenal aldosterone-producing adenoma
| Variable | Value |
|---|---|
| No. of males (%) | 79 (44.6%) |
| Age of operation (years) (Median, IQR) | 46 (38–53) |
| BMI (kg/m2) (Median, IQR) | 23.4 (21.5–25.5) |
| Duration of hypertension (years) (Median, IQR) | 5.5 (2.0–10.0) |
| Preoperative SBPmax (mmHg) (Median, IQR) | 140 (130–158) |
| Number of preoperative antihypertensive medicine(Median, IQR) | 2 (2–3) |
| Surgery type | |
| Partial adrenalectomy | 109 (61.6%) |
| Total unilateral adrenalectomy | 68 (38.4%) |
| Surgery approach | |
| Transperitoneal | 70 (39.5%) |
| Retroperitoneal | 107 (60.5%) |
| Operating time (min) (Median, IQR) | 105 (85–130) |
| Adenoma diameter (cm) (Median, IQR) | 1.5 (1.2–2.0) |
| Preoperative eGFR (mL/min/1.73m2) (Median, IQR) | 102 (84–118) |
| Preoperative serum aldosterone (ng/dL) (Median, IQR) | 466 (306–700) |
| Preoperative serum potassium (mmol/L) (Median, IQR) | 3.9 (3.6–4.1) |
| Postoperative blood pressure (mmHg) (Median, IQR) | 160 (150–170) |
Figure 1Primary hyperaldosteronism in a 59-year-old male patient
(A and B) CT image (plain and contrast) of primary adrenal aldosterone-producing adenoma. (C and D) Specimen picture of aldosterone-producing adenoma. (E) H & E staining of the aldosterone-producing adenoma (10 × 10).
Univariate analysis of risk factors for postoperative hypertension urgency
| Variable | NPHU group | PHU group | |
|---|---|---|---|
| Male | 67/148 (45.3%) | 12/29 (41.4%) | 0.702 |
| Age of operation (years) (Median, IQR) | 46 (38–52) | 50 (39–56) | 0.388 |
| BMI (kg/m2) (Median, IQR) | 23.5 (21.6–25.4) | 22.7 (21.5–26.5) | 0.625 |
| Preoperative SBPmax (mmHg) (Median, IQR) | 140 (130–150) | 160 (150–173) | |
| Number of preoperative antihypertensive medicine (Median, IQR) | 2 (2–3) | 2 (2–3) | 0.393 |
| Preoperative spirolactone treatment | 126/148 (85.1%) | 23/29 (79.3%) | 0.435 |
| Duration of hypertension < 5 years | 72/148 (48.6%) | 4/29 (13.8%) | |
| Surgical method, partial | 96/148 (64.9%) | 13/29 (44.8%) | |
| Surgical approach, transperitoneal | 59/148 (39.9%) | 11/29 (37.9%) | 0.847 |
| Adenoma diameter (cm) (Median, IQR) | 1.5 (1.2–2.0) | 1.5 (1.2–2.0) | 0.856 |
| Preoperative proteinuria | 5/148 (3.4%) | 2/29 (6.9%) | 0.377 |
| Preoperative eGFR (ml/min/1.73 m2) (Median, IQR) | 101 (83–115) | 111 (88–124) | 0.251 |
| Preoperative serum potassium (mmol/L) (< 3.5 mmol/L) | 17/148 (11.5%) | 9/29 (31.0%) | |
| Preoperative serum aldosterone (pg/ml) | 467 (294–686) | 451 (342–766) | 0.215 |
NPHU: non-postoperative hypertensive urgency; PHU: postoperative hypertensive urgency. *p < 0.05, **p < 0.01
Figure 2ROC curve indicated that preoperative SBPmax can accurately predict the occurrence of postoperative hypertensive urgency
The cut-off point was 157 mmHg, with the sensitivity of 66% and specificity of 82%.
Univariate analysis of risk factors for higher postoperative SBP
| Variable | Value | |
|---|---|---|
| Male | 44.6% | 0.161 |
| Age of operation (years) (Median, IQR) | 46 (38–53) | 0.081 |
| BMI (kg/m2) (Median, IQR) | 23.4 (21.5–25.5) | 0.351 |
| Preoperative SBPmax (mmHg) (Median, IQR) | 140 (130–158) | |
| Number of preoperative antihypertensive medicine (Median, IQR) | 2 (2–3) | |
| Preoperative spirolactone treatment | 84.2% | 0.224 |
| Duration of hypertension (< 5 years) | 42.9% | |
| Surgical method (partial) | 61.6% | 0.140 |
| Surgical approach (transperitoneal) | 39.5% | 0.445 |
| Adenoma diameter (cm) (Median, IQR) | 1.5 (1.2–2.0) | 0.421 |
| Preoperative proteinuria | 4% | 0.294 |
| eGFR (ml/min/1.73 m2) (Median, IQR) | 102 (84–118) | 0.883 |
| Preoperative serum potassium (< 3.5 mmol/L) | 14.7% | |
| Preoperavite serum aldosterone (pg/ml) | 466 (306–700) | 0.275 |
*p < 0.05, **p < 0.01.